Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.58066936 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.58066936 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.39473842 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.39473842 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.92991344 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73180785 |
7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47436328 |
8 | kynurenine metabolic process (GO:0070189) | 5.44726762 |
9 | tryptophan catabolic process (GO:0006569) | 5.37785653 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.37785653 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.37785653 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.31042992 |
13 | negative regulation of fibrinolysis (GO:0051918) | 5.30200343 |
14 | glyoxylate metabolic process (GO:0046487) | 5.28395026 |
15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.20699204 |
16 | bile acid biosynthetic process (GO:0006699) | 5.15901993 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13810903 |
18 | protein carboxylation (GO:0018214) | 5.13810903 |
19 | urea metabolic process (GO:0019627) | 5.09422191 |
20 | urea cycle (GO:0000050) | 5.09422191 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.07083216 |
22 | tryptophan metabolic process (GO:0006568) | 5.06364945 |
23 | cysteine metabolic process (GO:0006534) | 5.00200228 |
24 | complement activation, alternative pathway (GO:0006957) | 5.00055100 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.99370964 |
26 | regulation of protein activation cascade (GO:2000257) | 4.92951753 |
27 | regulation of fibrinolysis (GO:0051917) | 4.91525449 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79043768 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78834140 |
30 | regulation of complement activation (GO:0030449) | 4.64377698 |
31 | nitrogen cycle metabolic process (GO:0071941) | 4.63936865 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.59617829 |
33 | lysine catabolic process (GO:0006554) | 4.56761706 |
34 | lysine metabolic process (GO:0006553) | 4.56761706 |
35 | homocysteine metabolic process (GO:0050667) | 4.54036277 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 4.52822241 |
37 | reverse cholesterol transport (GO:0043691) | 4.44095954 |
38 | bile acid metabolic process (GO:0008206) | 4.42775910 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.35514115 |
40 | negative regulation of sterol transport (GO:0032372) | 4.30316945 |
41 | negative regulation of cholesterol transport (GO:0032375) | 4.30316945 |
42 | plasma lipoprotein particle clearance (GO:0034381) | 4.29937357 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 4.28728269 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24588676 |
45 | protein-lipid complex remodeling (GO:0034368) | 4.24588676 |
46 | macromolecular complex remodeling (GO:0034367) | 4.24588676 |
47 | regulation of cholesterol esterification (GO:0010872) | 4.23718711 |
48 | phospholipid efflux (GO:0033700) | 4.22558024 |
49 | triglyceride homeostasis (GO:0070328) | 4.22179933 |
50 | acylglycerol homeostasis (GO:0055090) | 4.22179933 |
51 | tyrosine metabolic process (GO:0006570) | 4.13552471 |
52 | alpha-amino acid catabolic process (GO:1901606) | 4.12483082 |
53 | regulation of cholesterol homeostasis (GO:2000188) | 4.04848055 |
54 | glycine metabolic process (GO:0006544) | 3.91819946 |
55 | ethanol oxidation (GO:0006069) | 3.87583724 |
56 | cellular modified amino acid catabolic process (GO:0042219) | 3.84456188 |
57 | barbed-end actin filament capping (GO:0051016) | 3.83295717 |
58 | bile acid and bile salt transport (GO:0015721) | 3.82920820 |
59 | cellular amino acid catabolic process (GO:0009063) | 3.81429178 |
60 | fibrinolysis (GO:0042730) | 3.79098937 |
61 | plasma lipoprotein particle assembly (GO:0034377) | 3.77681600 |
62 | cholesterol efflux (GO:0033344) | 3.76719332 |
63 | coenzyme catabolic process (GO:0009109) | 3.75531134 |
64 | benzene-containing compound metabolic process (GO:0042537) | 3.74356040 |
65 | serine family amino acid metabolic process (GO:0009069) | 3.73533720 |
66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73286786 |
67 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71527924 |
68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71527924 |
69 | cellular ketone body metabolic process (GO:0046950) | 3.71462564 |
70 | glutamate metabolic process (GO:0006536) | 3.69763316 |
71 | phospholipid homeostasis (GO:0055091) | 3.69383862 |
72 | cellular glucuronidation (GO:0052695) | 3.68324631 |
73 | indolalkylamine metabolic process (GO:0006586) | 3.67532476 |
74 | positive regulation of lipid catabolic process (GO:0050996) | 3.67226604 |
75 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64158590 |
76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62400207 |
77 | imidazole-containing compound metabolic process (GO:0052803) | 3.61475160 |
78 | amine catabolic process (GO:0009310) | 3.58966966 |
79 | cellular biogenic amine catabolic process (GO:0042402) | 3.58966966 |
80 | arginine metabolic process (GO:0006525) | 3.57655626 |
81 | cholesterol homeostasis (GO:0042632) | 3.55283506 |
82 | protein-lipid complex assembly (GO:0065005) | 3.51533186 |
83 | sterol homeostasis (GO:0055092) | 3.51222825 |
84 | serine family amino acid biosynthetic process (GO:0009070) | 3.49966956 |
85 | acetyl-CoA metabolic process (GO:0006084) | 3.49665510 |
86 | neutrophil activation involved in immune response (GO:0002283) | 3.49404123 |
87 | negative regulation of lipase activity (GO:0060192) | 3.49339605 |
88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49038151 |
89 | drug catabolic process (GO:0042737) | 3.45257239 |
90 | complement activation, classical pathway (GO:0006958) | 3.44120403 |
91 | complement activation (GO:0006956) | 3.44086823 |
92 | valine metabolic process (GO:0006573) | 3.43797462 |
93 | acute-phase response (GO:0006953) | 3.42839283 |
94 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40951522 |
95 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40951522 |
96 | modulation by symbiont of host immune response (GO:0052553) | 3.40951522 |
97 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40951522 |
98 | modulation by symbiont of host defense response (GO:0052031) | 3.40951522 |
99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40951522 |
100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.40895954 |
101 | organic acid catabolic process (GO:0016054) | 3.38895264 |
102 | carboxylic acid catabolic process (GO:0046395) | 3.38895264 |
103 | protein activation cascade (GO:0072376) | 3.38031214 |
104 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.37021099 |
105 | fatty acid beta-oxidation (GO:0006635) | 3.35541007 |
106 | lipoprotein metabolic process (GO:0042157) | 3.34363057 |
107 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34333631 |
108 | negative regulation of cell killing (GO:0031342) | 3.34333631 |
109 | fatty acid oxidation (GO:0019395) | 3.34320129 |
110 | plasma lipoprotein particle organization (GO:0071827) | 3.33799186 |
111 | short-chain fatty acid metabolic process (GO:0046459) | 3.30473787 |
112 | regulation of plasminogen activation (GO:0010755) | 3.29461278 |
113 | epoxygenase P450 pathway (GO:0019373) | 3.29134443 |
114 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.29116522 |
115 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26349013 |
116 | detection of other organism (GO:0098543) | 3.24622762 |
117 | detection of molecule of bacterial origin (GO:0032490) | 3.18492973 |
118 | positive regulation of receptor recycling (GO:0001921) | 3.17393977 |
119 | detection of bacterium (GO:0016045) | 3.04221111 |
120 | detection of external biotic stimulus (GO:0098581) | 3.03754144 |
121 | response to peptidoglycan (GO:0032494) | 2.94918411 |
122 | protein localization to endosome (GO:0036010) | 2.94897671 |
123 | macrophage activation involved in immune response (GO:0002281) | 2.92839658 |
124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80890400 |
125 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79090724 |
126 | fibril organization (GO:0097435) | 2.71616105 |
127 | stress fiber assembly (GO:0043149) | 2.62389231 |
128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62322524 |
129 | detection of biotic stimulus (GO:0009595) | 2.62099280 |
130 | regulation of leukocyte degranulation (GO:0043300) | 2.60475173 |
131 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56024556 |
132 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.55687623 |
133 | regulation of mast cell degranulation (GO:0043304) | 2.55183972 |
134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53734393 |
135 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.53674730 |
136 | extracellular fibril organization (GO:0043206) | 2.51674174 |
137 | negative regulation of interleukin-12 production (GO:0032695) | 2.49280221 |
138 | regulation of macrophage cytokine production (GO:0010935) | 2.48328215 |
139 | germinal center formation (GO:0002467) | 2.48195130 |
140 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46409171 |
141 | regulation of tolerance induction (GO:0002643) | 2.46119229 |
142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44928728 |
143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43910886 |
144 | apoptotic cell clearance (GO:0043277) | 2.43626987 |
145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43103987 |
146 | response to laminar fluid shear stress (GO:0034616) | 2.42893960 |
147 | regulation of T cell tolerance induction (GO:0002664) | 2.41246863 |
148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40388515 |
149 | skin morphogenesis (GO:0043589) | 2.37864209 |
150 | endothelium development (GO:0003158) | 2.37074625 |
151 | NIK/NF-kappaB signaling (GO:0038061) | 2.36312999 |
152 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35664407 |
153 | negative regulation of stress fiber assembly (GO:0051497) | 2.34182485 |
154 | peptide catabolic process (GO:0043171) | 2.34041926 |
155 | neutrophil activation (GO:0042119) | 2.33174010 |
156 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.29275602 |
157 | response to host (GO:0075136) | 2.29167397 |
158 | response to host defenses (GO:0052200) | 2.29167397 |
159 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.29167397 |
160 | leukocyte aggregation (GO:0070486) | 2.28205443 |
161 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.28113252 |
162 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.27124842 |
163 | positive regulation of leukocyte degranulation (GO:0043302) | 2.27110535 |
164 | keratan sulfate catabolic process (GO:0042340) | 2.26795843 |
165 | granulocyte activation (GO:0036230) | 2.25363077 |
166 | cellular extravasation (GO:0045123) | 2.24877252 |
167 | angiogenesis involved in wound healing (GO:0060055) | 2.24168341 |
168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.22995083 |
169 | positive regulation of tolerance induction (GO:0002645) | 2.22930691 |
170 | positive regulation of mast cell activation (GO:0033005) | 2.18233932 |
171 | hypotonic response (GO:0006971) | 2.14939831 |
172 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.13606091 |
173 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.13399961 |
174 | response to host immune response (GO:0052572) | 2.12487323 |
175 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.12487323 |
176 | macrophage activation (GO:0042116) | 2.12259275 |
177 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.11987203 |
178 | phagocytosis, engulfment (GO:0006911) | 2.11948164 |
179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.10980064 |
180 | immunoglobulin mediated immune response (GO:0016064) | 2.09919150 |
181 | pinocytosis (GO:0006907) | 2.08563062 |
182 | regulation of platelet aggregation (GO:0090330) | 2.07782386 |
183 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.07522477 |
184 | regulation of regulated secretory pathway (GO:1903305) | 2.07516488 |
185 | response to muramyl dipeptide (GO:0032495) | 2.07319584 |
186 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.05571374 |
187 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.05487159 |
188 | blood vessel maturation (GO:0001955) | 2.05132439 |
189 | negative regulation of type 2 immune response (GO:0002829) | 2.04844076 |
190 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.04749045 |
191 | mannose metabolic process (GO:0006013) | 2.04659188 |
192 | negative regulation of granulocyte differentiation (GO:0030853) | 2.03735351 |
193 | cellular response to epinephrine stimulus (GO:0071872) | 2.03508791 |
194 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.03375679 |
195 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.02293107 |
196 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.01827265 |
197 | positive regulation of macrophage cytokine production (GO:0060907) | 1.99828025 |
198 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 1.99341581 |
199 | positive regulation of mast cell degranulation (GO:0043306) | 1.99341581 |
200 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 1.97806363 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.16515148 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.32793407 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.61890252 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.18160472 |
5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.17667207 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.38899655 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.95886460 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.53591769 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.00551903 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42292509 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.38732204 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36671382 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.10408128 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00258468 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0305684 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.89132568 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87677637 |
18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84300531 |
19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81505734 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79104143 |
21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78037429 |
22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73640001 |
23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70241222 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69762367 |
25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.69368480 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69051268 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68340962 |
28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66765424 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61578360 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55658066 |
31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52260963 |
32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.47554525 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47168433 |
34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44663923 |
35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43535042 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41523882 |
37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39929160 |
38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38603018 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35876307 |
40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33379215 |
41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32579656 |
42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32264802 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30565213 |
44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30484040 |
45 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28022154 |
46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25145692 |
47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23995754 |
48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23341727 |
49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22221204 |
50 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.19865800 |
51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19819618 |
52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17484956 |
53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17269845 |
54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17081844 |
55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16769073 |
56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15894311 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12413151 |
58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10679875 |
59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10373190 |
60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10359628 |
61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09922730 |
62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09574000 |
63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07654320 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05684379 |
65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05571764 |
66 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05560120 |
67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03035828 |
68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02597303 |
69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02070062 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00518522 |
71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00391201 |
72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99939569 |
73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99742170 |
74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99729344 |
75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99465882 |
76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99424405 |
77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99424405 |
78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99209408 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99174090 |
80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99114328 |
81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98966499 |
82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98258151 |
83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98017760 |
84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97942582 |
85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97917049 |
86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97850926 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96915627 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96092073 |
89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94551247 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93748222 |
91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93558823 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93291577 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93234759 |
94 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91299446 |
95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88481903 |
96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81730893 |
97 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81356907 |
98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81042253 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80941205 |
100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80941205 |
101 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80799121 |
102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80298449 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80001082 |
104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79101892 |
105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77403045 |
106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76708361 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76574168 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76130538 |
109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74362233 |
110 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72967096 |
111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72291824 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71827694 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71741679 |
114 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.71236789 |
115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.70794556 |
116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70202854 |
117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70153565 |
118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69646706 |
119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69545843 |
120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67936192 |
121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67431677 |
122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67086039 |
123 | MAF_26560356_Chip-Seq_TH1_Human | 0.66951429 |
124 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66624601 |
125 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.66177691 |
126 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66144828 |
127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.65428609 |
128 | MYC_22102868_ChIP-Seq_BL_Human | 0.65349056 |
129 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64262666 |
130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.64241446 |
131 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.63861451 |
132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.63455959 |
133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.62896967 |
134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62170132 |
135 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.60637290 |
136 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.59532153 |
137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59457836 |
138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.59118076 |
139 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59009556 |
140 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.58379843 |
141 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58366010 |
142 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57831777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.99629340 |
2 | MP0005360_urolithiasis | 6.46262111 |
3 | MP0005365_abnormal_bile_salt | 5.33763080 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.33144737 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.22216963 |
6 | MP0009840_abnormal_foam_cell | 3.52866640 |
7 | MP0003252_abnormal_bile_duct | 3.48642975 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.45660134 |
9 | MP0010329_abnormal_lipoprotein_level | 3.25799773 |
10 | MP0005083_abnormal_biliary_tract | 2.84145635 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.74968018 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.49903731 |
13 | MP0005332_abnormal_amino_acid | 2.40452797 |
14 | MP0001835_abnormal_antigen_presentation | 2.36957760 |
15 | MP0001666_abnormal_nutrient_absorption | 2.36266210 |
16 | MP0001958_emphysema | 2.26280850 |
17 | MP0003195_calcinosis | 2.23884565 |
18 | MP0000609_abnormal_liver_physiology | 2.12277667 |
19 | MP0003828_pulmonary_edema | 1.99455906 |
20 | MP0006054_spinal_hemorrhage | 1.94592528 |
21 | MP0002118_abnormal_lipid_homeostasis | 1.91419677 |
22 | MP0002419_abnormal_innate_immunity | 1.91041057 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.84830140 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.84573923 |
25 | MP0005319_abnormal_enzyme/_coenzyme | 1.75816509 |
26 | MP0002998_abnormal_bone_remodeling | 1.69693004 |
27 | MP0003091_abnormal_cell_migration | 1.68164390 |
28 | MP0003172_abnormal_lysosome_physiology | 1.65282827 |
29 | MP0008260_abnormal_autophagy | 1.63797615 |
30 | MP0005025_abnormal_response_to | 1.61000952 |
31 | MP0005503_abnormal_tendon_morphology | 1.54835934 |
32 | MP0010368_abnormal_lymphatic_system | 1.53576903 |
33 | MP0003868_abnormal_feces_composition | 1.53355983 |
34 | MP0001790_abnormal_immune_system | 1.51015486 |
35 | MP0005387_immune_system_phenotype | 1.51015486 |
36 | MP0000343_altered_response_to | 1.49708096 |
37 | MP0000858_altered_metastatic_potential | 1.48404893 |
38 | MP0005451_abnormal_body_composition | 1.47562487 |
39 | MP0000465_gastrointestinal_hemorrhage | 1.47118464 |
40 | MP0004272_abnormal_basement_membrane | 1.46631561 |
41 | MP0002148_abnormal_hypersensitivity_rea | 1.45484182 |
42 | MP0008004_abnormal_stomach_pH | 1.44470635 |
43 | MP0004883_abnormal_blood_vessel | 1.43177537 |
44 | MP0009785_altered_susceptibility_to | 1.40782000 |
45 | MP0005000_abnormal_immune_tolerance | 1.40588745 |
46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35465119 |
47 | MP0004510_myositis | 1.34381646 |
48 | MP0005164_abnormal_response_to | 1.32555117 |
49 | MP0009643_abnormal_urine_homeostasis | 1.29384906 |
50 | MP0001542_abnormal_bone_strength | 1.28353747 |
51 | MP0003448_altered_tumor_morphology | 1.28344287 |
52 | MP0002877_abnormal_melanocyte_morpholog | 1.27679584 |
53 | MP0000598_abnormal_liver_morphology | 1.26305214 |
54 | MP0008438_abnormal_cutaneous_collagen | 1.25958074 |
55 | MP0002254_reproductive_system_inflammat | 1.25584056 |
56 | MP0005670_abnormal_white_adipose | 1.24853816 |
57 | MP0005257_abnormal_intraocular_pressure | 1.24498791 |
58 | MP0002452_abnormal_antigen_presenting | 1.23368314 |
59 | MP0001849_ear_inflammation | 1.21610259 |
60 | MP0010155_abnormal_intestine_physiology | 1.21335029 |
61 | MP0002723_abnormal_immune_serum | 1.16760052 |
62 | MP0005390_skeleton_phenotype | 1.14459788 |
63 | MP0001764_abnormal_homeostasis | 1.13958205 |
64 | MP0002420_abnormal_adaptive_immunity | 1.12704389 |
65 | MP0001800_abnormal_humoral_immune | 1.11727157 |
66 | MP0001819_abnormal_immune_cell | 1.11533181 |
67 | MP0001851_eye_inflammation | 1.08908632 |
68 | MP0002896_abnormal_bone_mineralization | 1.05613575 |
69 | MP0003186_abnormal_redox_activity | 1.05499324 |
70 | MP0004130_abnormal_muscle_cell | 1.04956141 |
71 | MP0009764_decreased_sensitivity_to | 1.04568998 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.04273866 |
73 | MP0003183_abnormal_peptide_metabolism | 1.02803843 |
74 | MP0003300_gastrointestinal_ulcer | 1.01853525 |
75 | MP0003011_delayed_dark_adaptation | 1.01645590 |
76 | MP0005595_abnormal_vascular_smooth | 1.00215260 |
77 | MP0009763_increased_sensitivity_to | 0.98569855 |
78 | MP0002405_respiratory_system_inflammati | 0.97435360 |
79 | MP0008469_abnormal_protein_level | 0.94919884 |
80 | MP0005409_darkened_coat_color | 0.94887407 |
81 | MP0000604_amyloidosis | 0.94735587 |
82 | MP0004858_abnormal_nervous_system | 0.93178314 |
83 | MP0005671_abnormal_response_to | 0.92073704 |
84 | MP0003795_abnormal_bone_structure | 0.90509769 |
85 | MP0005647_abnormal_sex_gland | 0.90084437 |
86 | MP0005397_hematopoietic_system_phenotyp | 0.88791749 |
87 | MP0001545_abnormal_hematopoietic_system | 0.88791749 |
88 | MP0009697_abnormal_copulation | 0.88132213 |
89 | MP0005666_abnormal_adipose_tissue | 0.87305277 |
90 | MP0009278_abnormal_bone_marrow | 0.85887705 |
91 | MP0003436_decreased_susceptibility_to | 0.84366303 |
92 | MP0005023_abnormal_wound_healing | 0.83667677 |
93 | MP0002933_joint_inflammation | 0.83650385 |
94 | MP0002971_abnormal_brown_adipose | 0.82843612 |
95 | MP0005388_respiratory_system_phenotype | 0.82251958 |
96 | MP0002133_abnormal_respiratory_system | 0.82251958 |
97 | MP0005275_abnormal_skin_tensile | 0.81305152 |
98 | MP0005165_increased_susceptibility_to | 0.80589364 |
99 | MP0005464_abnormal_platelet_physiology | 0.80470456 |
100 | MP0000751_myopathy | 0.80055182 |
101 | MP0004381_abnormal_hair_follicle | 0.79897296 |
102 | MP0001879_abnormal_lymphatic_vessel | 0.79250294 |
103 | MP0000750_abnormal_muscle_regeneration | 0.79172878 |
104 | MP0009642_abnormal_blood_homeostasis | 0.79092143 |
105 | MP0005058_abnormal_lysosome_morphology | 0.78174723 |
106 | MP0005501_abnormal_skin_physiology | 0.76942228 |
107 | MP0009384_cardiac_valve_regurgitation | 0.75466652 |
108 | MP0002060_abnormal_skin_morphology | 0.75341451 |
109 | MP0005636_abnormal_mineral_homeostasis | 0.75316692 |
110 | MP0005076_abnormal_cell_differentiation | 0.74956239 |
111 | MP0009053_abnormal_anal_canal | 0.74857191 |
112 | MP0003566_abnormal_cell_adhesion | 0.74658355 |
113 | MP0005334_abnormal_fat_pad | 0.73423042 |
114 | MP0005508_abnormal_skeleton_morphology | 0.73062135 |
115 | MP0005220_abnormal_exocrine_pancreas | 0.72407396 |
116 | MP0002132_abnormal_respiratory_system | 0.72302442 |
117 | MP0005408_hypopigmentation | 0.72063636 |
118 | MP0001756_abnormal_urination | 0.70988090 |
119 | MP0002796_impaired_skin_barrier | 0.68560033 |
120 | MP0004185_abnormal_adipocyte_glucose | 0.67766556 |
121 | MP0004947_skin_inflammation | 0.66639285 |
122 | MP0002136_abnormal_kidney_physiology | 0.65029714 |
123 | MP0003279_aneurysm | 0.63887708 |
124 | MP0002078_abnormal_glucose_homeostasis | 0.62872731 |
125 | MP0003453_abnormal_keratinocyte_physiol | 0.62853580 |
126 | MP0005376_homeostasis/metabolism_phenot | 0.61285413 |
127 | MP0010234_abnormal_vibrissa_follicle | 0.59842783 |
128 | MP0001243_abnormal_dermal_layer | 0.59583853 |
129 | MP0000249_abnormal_blood_vessel | 0.59296214 |
130 | MP0009115_abnormal_fat_cell | 0.59176718 |
131 | MP0003724_increased_susceptibility_to | 0.58788751 |
132 | MP0002168_other_aberrant_phenotype | 0.57464438 |
133 | MP0006082_CNS_inflammation | 0.56960368 |
134 | MP0009765_abnormal_xenobiotic_induced | 0.56678165 |
135 | MP0001661_extended_life_span | 0.56067230 |
136 | MP0000685_abnormal_immune_system | 0.55162442 |
137 | MP0001853_heart_inflammation | 0.54752491 |
138 | MP0006036_abnormal_mitochondrial_physio | 0.54278933 |
139 | MP0002837_dystrophic_cardiac_calcinosis | 0.51773425 |
140 | MP0001915_intracranial_hemorrhage | 0.50258440 |
141 | MP0001845_abnormal_inflammatory_respons | 0.49971335 |
142 | MP0002928_abnormal_bile_duct | 0.47906363 |
143 | MP0005375_adipose_tissue_phenotype | 0.47831244 |
144 | MP0000639_abnormal_adrenal_gland | 0.47770242 |
145 | MP0003075_altered_response_to | 0.47544166 |
146 | MP0005084_abnormal_gallbladder_morpholo | 0.46684123 |
147 | MP0005166_decreased_susceptibility_to | 0.46446627 |
148 | MP0001533_abnormal_skeleton_physiology | 0.46143896 |
149 | MP0003690_abnormal_glial_cell | 0.45936695 |
150 | MP0005395_other_phenotype | 0.44849948 |
151 | MP0002128_abnormal_blood_circulation | 0.44658990 |
152 | MP0003303_peritoneal_inflammation | 0.44545262 |
153 | MP0005266_abnormal_metabolism | 0.44330308 |
154 | MP0005448_abnormal_energy_balance | 0.43915406 |
155 | MP0003638_abnormal_response/metabolism_ | 0.43902748 |
156 | MP0002970_abnormal_white_adipose | 0.43621222 |
157 | MP0005167_abnormal_blood-brain_barrier | 0.43121984 |
158 | MP0000767_abnormal_smooth_muscle | 0.42702360 |
159 | MP0001881_abnormal_mammary_gland | 0.42688832 |
160 | MP0002135_abnormal_kidney_morphology | 0.42355805 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.00525066 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.24592795 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.21994823 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.89629201 |
5 | Xanthomatosis (HP:0000991) | 5.88839124 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.38734655 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.29937071 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.15552573 |
9 | Complement deficiency (HP:0004431) | 4.99747123 |
10 | Hypolipoproteinemia (HP:0010981) | 4.32149144 |
11 | Joint hemorrhage (HP:0005261) | 4.23748925 |
12 | Hyperammonemia (HP:0001987) | 4.21659438 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.18410696 |
14 | Hypoalphalipoproteinemia (HP:0003233) | 4.06057295 |
15 | Eczematoid dermatitis (HP:0000976) | 4.02560034 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.02366221 |
17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97245830 |
18 | Epidermoid cyst (HP:0200040) | 3.94289931 |
19 | Ketosis (HP:0001946) | 3.90193530 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84228996 |
21 | Abnormality of complement system (HP:0005339) | 3.72535027 |
22 | Hyperglycinemia (HP:0002154) | 3.65573950 |
23 | Hyperglycinuria (HP:0003108) | 3.57521286 |
24 | Hypoglycemic coma (HP:0001325) | 3.54224160 |
25 | Abnormality of methionine metabolism (HP:0010901) | 3.50398878 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.49502274 |
27 | Abnormality of the nasal mucosa (HP:0000433) | 3.48662432 |
28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47544824 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.47544824 |
30 | Fat malabsorption (HP:0002630) | 3.46924920 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41747618 |
32 | Myocardial infarction (HP:0001658) | 3.38997930 |
33 | Hypercholesterolemia (HP:0003124) | 3.38195853 |
34 | Abnormality of macrophages (HP:0004311) | 3.32743200 |
35 | Aortic aneurysm (HP:0004942) | 3.28749495 |
36 | Nasal polyposis (HP:0100582) | 3.19758771 |
37 | Vascular tortuosity (HP:0004948) | 3.18429701 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16417661 |
39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.13219591 |
40 | Recurrent abscess formation (HP:0002722) | 3.11481293 |
41 | Spontaneous hematomas (HP:0007420) | 3.09546769 |
42 | Premature rupture of membranes (HP:0001788) | 3.08856341 |
43 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05299698 |
44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05299698 |
45 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05299698 |
46 | Arterial tortuosity (HP:0005116) | 3.04366024 |
47 | Recurrent bacterial skin infections (HP:0005406) | 3.03358359 |
48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02247476 |
49 | Chronic otitis media (HP:0000389) | 2.97893316 |
50 | Systemic lupus erythematosus (HP:0002725) | 2.95359938 |
51 | Hepatocellular carcinoma (HP:0001402) | 2.88379958 |
52 | Aortic dissection (HP:0002647) | 2.84722626 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82974962 |
54 | Dysostosis multiplex (HP:0000943) | 2.80686884 |
55 | Ketoacidosis (HP:0001993) | 2.77595584 |
56 | Skin nodule (HP:0200036) | 2.72712573 |
57 | Hyperbilirubinemia (HP:0002904) | 2.71925811 |
58 | Abnormality of purine metabolism (HP:0004352) | 2.67852648 |
59 | Esophageal varix (HP:0002040) | 2.66909182 |
60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.66325444 |
61 | Mitral stenosis (HP:0001718) | 2.63886218 |
62 | Steatorrhea (HP:0002570) | 2.61891907 |
63 | Vascular calcification (HP:0004934) | 2.59480457 |
64 | Spontaneous abortion (HP:0005268) | 2.58273252 |
65 | Spastic diplegia (HP:0001264) | 2.58096854 |
66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57173919 |
67 | Osteolytic defects of the hand bones (HP:0009699) | 2.57173919 |
68 | Emphysema (HP:0002097) | 2.56003818 |
69 | Delayed CNS myelination (HP:0002188) | 2.55463561 |
70 | Dilatation of the ascending aorta (HP:0005111) | 2.54238965 |
71 | Increased IgE level (HP:0003212) | 2.53247756 |
72 | Vertebral compression fractures (HP:0002953) | 2.53214270 |
73 | Purpura (HP:0000979) | 2.51606515 |
74 | Cerebral aneurysm (HP:0004944) | 2.51045619 |
75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50977019 |
76 | Cardiovascular calcification (HP:0011915) | 2.47563924 |
77 | Asymmetric septal hypertrophy (HP:0001670) | 2.45660829 |
78 | Gout (HP:0001997) | 2.44070468 |
79 | Cervical subluxation (HP:0003308) | 2.43181894 |
80 | Spondylolisthesis (HP:0003302) | 2.43032868 |
81 | Distal lower limb muscle weakness (HP:0009053) | 2.42642158 |
82 | Abnormality of serum amino acid levels (HP:0003112) | 2.41174282 |
83 | Gingival bleeding (HP:0000225) | 2.38991987 |
84 | Gingivitis (HP:0000230) | 2.38523705 |
85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36709446 |
86 | Metabolic acidosis (HP:0001942) | 2.33489252 |
87 | Increased connective tissue (HP:0009025) | 2.32974281 |
88 | Prolonged bleeding time (HP:0003010) | 2.31268492 |
89 | Glomerulonephritis (HP:0000099) | 2.30318086 |
90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30268058 |
91 | Dicarboxylic aciduria (HP:0003215) | 2.30268058 |
92 | Type 1 muscle fiber predominance (HP:0003803) | 2.28807925 |
93 | Hemorrhage of the eye (HP:0011885) | 2.27106536 |
94 | Menorrhagia (HP:0000132) | 2.25790733 |
95 | Neonatal onset (HP:0003623) | 2.25687100 |
96 | Cholelithiasis (HP:0001081) | 2.25369487 |
97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25280444 |
98 | Mucopolysacchariduria (HP:0008155) | 2.22859419 |
99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22859419 |
100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22674455 |
101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22674455 |
102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22674455 |
103 | Myositis (HP:0100614) | 2.22564583 |
104 | Abnormal gallbladder morphology (HP:0012437) | 2.21820998 |
105 | Abnormality of proline metabolism (HP:0010907) | 2.18956815 |
106 | Hydroxyprolinuria (HP:0003080) | 2.18956815 |
107 | Hypochromic microcytic anemia (HP:0004840) | 2.18780031 |
108 | Malnutrition (HP:0004395) | 2.18701864 |
109 | Aneurysm (HP:0002617) | 2.15915572 |
110 | Late onset (HP:0003584) | 2.14917118 |
111 | Epistaxis (HP:0000421) | 2.14614044 |
112 | Increased cerebral lipofuscin (HP:0011813) | 2.14112647 |
113 | Axonal loss (HP:0003447) | 2.12793923 |
114 | Joint stiffness (HP:0001387) | 2.11793887 |
115 | Thrombophlebitis (HP:0004418) | 2.11500114 |
116 | Abnormal cartilage morphology (HP:0002763) | 2.11257635 |
117 | Amyloidosis (HP:0011034) | 2.11192844 |
118 | Orchitis (HP:0100796) | 2.10014695 |
119 | Neurofibrillary tangles (HP:0002185) | 2.09832200 |
120 | Cellulitis (HP:0100658) | 2.09072270 |
121 | Abnormality of iron homeostasis (HP:0011031) | 2.08916440 |
122 | Blue sclerae (HP:0000592) | 2.08629816 |
123 | Recurrent bronchitis (HP:0002837) | 2.04550761 |
124 | Hyporeflexia of lower limbs (HP:0002600) | 2.03555757 |
125 | Polycythemia (HP:0001901) | 2.03481837 |
126 | Vacuolated lymphocytes (HP:0001922) | 2.03420890 |
127 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03318848 |
128 | Hypoglycemic seizures (HP:0002173) | 2.00476694 |
129 | Lethargy (HP:0001254) | 1.99891860 |
130 | Pancreatitis (HP:0001733) | 1.98963193 |
131 | Abnormal platelet volume (HP:0011876) | 1.98801612 |
132 | Nephritis (HP:0000123) | 1.97962213 |
133 | Genu recurvatum (HP:0002816) | 1.97368175 |
134 | Cholecystitis (HP:0001082) | 1.96262686 |
135 | Abnormal gallbladder physiology (HP:0012438) | 1.96262686 |
136 | Gastrointestinal infarctions (HP:0005244) | 1.95982517 |
137 | Peritonitis (HP:0002586) | 1.95864824 |
138 | Ovoid vertebral bodies (HP:0003300) | 1.92955435 |
139 | Acanthocytosis (HP:0001927) | 1.92665022 |
140 | Recurrent skin infections (HP:0001581) | 1.91238057 |
141 | Irritability (HP:0000737) | 1.91025494 |
142 | Mitral valve prolapse (HP:0001634) | 1.90073052 |
143 | Back pain (HP:0003418) | 1.89795331 |
144 | Broad metatarsal (HP:0001783) | 1.89692790 |
145 | Sensorimotor neuropathy (HP:0007141) | 1.89275818 |
146 | Protrusio acetabuli (HP:0003179) | 1.88972754 |
147 | Abnormality of the Achilles tendon (HP:0005109) | 1.88317428 |
148 | Spinal rigidity (HP:0003306) | 1.88296983 |
149 | Thin bony cortex (HP:0002753) | 1.84478647 |
150 | Atrophic scars (HP:0001075) | 1.84350434 |
151 | Increased mean platelet volume (HP:0011877) | 1.83974301 |
152 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83660963 |
153 | Petechiae (HP:0000967) | 1.82044749 |
154 | Slender build (HP:0001533) | 1.81156084 |
155 | Hypertriglyceridemia (HP:0002155) | 1.81065406 |
156 | Muscle fiber splitting (HP:0003555) | 1.80563161 |
157 | Abnormality of the gallbladder (HP:0005264) | 1.79768165 |
158 | Pulmonary embolism (HP:0002204) | 1.79164820 |
159 | Ectopia lentis (HP:0001083) | 1.78613544 |
160 | Loss of speech (HP:0002371) | 1.77851430 |
161 | Increased serum ferritin (HP:0003281) | 1.77440241 |
162 | Stroke (HP:0001297) | 1.77023534 |
163 | Generalized aminoaciduria (HP:0002909) | 1.75748306 |
164 | Cerebral inclusion bodies (HP:0100314) | 1.75509331 |
165 | Hematochezia (HP:0002573) | 1.75041864 |
166 | Hyperglycemia (HP:0003074) | 1.75017871 |
167 | Lymphangioma (HP:0100764) | 1.74871387 |
168 | Right ventricular cardiomyopathy (HP:0011663) | 1.74600773 |
169 | Mediastinal lymphadenopathy (HP:0100721) | 1.73927629 |
170 | Fragile skin (HP:0001030) | 1.73512773 |
171 | Ulnar deviation of the wrist (HP:0003049) | 1.72712637 |
172 | Thick nail (HP:0001805) | 1.72705239 |
173 | Vomiting (HP:0002013) | 1.72637363 |
174 | Ankle contracture (HP:0006466) | 1.70796107 |
175 | Generalized amyotrophy (HP:0003700) | 1.69829473 |
176 | Opisthotonus (HP:0002179) | 1.69661471 |
177 | Striae distensae (HP:0001065) | 1.68992102 |
178 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66996570 |
179 | Interstitial pulmonary disease (HP:0006530) | 1.64579884 |
180 | Abnormality of the peritoneum (HP:0002585) | 1.64512899 |
181 | Premature loss of primary teeth (HP:0006323) | 1.63178493 |
182 | Bruising susceptibility (HP:0000978) | 1.62237477 |
183 | Difficulty running (HP:0009046) | 1.60339233 |
184 | Nuclear cataract (HP:0100018) | 1.60302036 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.59326967 |
2 | BCKDK | 4.40381486 |
3 | MAP3K13 | 4.38473877 |
4 | TRIB3 | 3.97864041 |
5 | SIK1 | 3.75450870 |
6 | FGFR4 | 3.74215699 |
7 | PKN2 | 3.36506244 |
8 | PRPF4B | 2.43185689 |
9 | RIPK4 | 2.21377292 |
10 | PTK6 | 2.06988237 |
11 | MAP3K10 | 2.03418952 |
12 | TAOK3 | 2.01508103 |
13 | LATS1 | 2.00175242 |
14 | BLK | 1.90689014 |
15 | ARAF | 1.86087112 |
16 | TGFBR2 | 1.85044837 |
17 | EPHB1 | 1.77461063 |
18 | TYK2 | 1.70730930 |
19 | TTN | 1.68094318 |
20 | KDR | 1.64481379 |
21 | RIPK1 | 1.62868348 |
22 | MAP2K3 | 1.62787828 |
23 | FLT3 | 1.53620944 |
24 | MOS | 1.51177893 |
25 | MST1R | 1.50922412 |
26 | KSR2 | 1.48599910 |
27 | TIE1 | 1.46150476 |
28 | MYLK | 1.43875565 |
29 | FES | 1.42770558 |
30 | NEK9 | 1.40000857 |
31 | ERBB4 | 1.36777007 |
32 | TBK1 | 1.33512318 |
33 | MAPK11 | 1.28205036 |
34 | MAP3K1 | 1.26815505 |
35 | EEF2K | 1.26022010 |
36 | JAK1 | 1.23055007 |
37 | MAP4K1 | 1.20794236 |
38 | TESK1 | 1.19852287 |
39 | CDC42BPA | 1.19293525 |
40 | PRKD2 | 1.18344123 |
41 | PDGFRA | 1.16849206 |
42 | TAOK1 | 1.16564508 |
43 | IRAK4 | 1.16534116 |
44 | PIK3CG | 1.15495834 |
45 | MAP3K7 | 1.12955345 |
46 | INSRR | 1.12350715 |
47 | FGFR2 | 1.11805422 |
48 | LRRK2 | 1.11448878 |
49 | EPHA3 | 1.10267517 |
50 | MARK2 | 1.09828099 |
51 | CAMK1D | 1.08599090 |
52 | MAP3K3 | 1.04613092 |
53 | CDK6 | 1.00864723 |
54 | FGFR3 | 1.00323761 |
55 | STK38 | 0.98219328 |
56 | JAK2 | 0.97501231 |
57 | PTK2 | 0.96905913 |
58 | FGR | 0.95294715 |
59 | MAP3K6 | 0.93006848 |
60 | STK10 | 0.91349204 |
61 | BMPR2 | 0.90289441 |
62 | ILK | 0.90255569 |
63 | TAOK2 | 0.89491288 |
64 | SMG1 | 0.86075339 |
65 | PRKAA2 | 0.85289252 |
66 | BMX | 0.85116718 |
67 | ZAP70 | 0.85056778 |
68 | CSK | 0.84913526 |
69 | KSR1 | 0.84733070 |
70 | JAK3 | 0.84610107 |
71 | MTOR | 0.82875294 |
72 | ICK | 0.82838789 |
73 | MAP3K11 | 0.82122553 |
74 | GRK6 | 0.76205870 |
75 | MAP2K4 | 0.75728794 |
76 | BRAF | 0.74676632 |
77 | MET | 0.73692565 |
78 | RPS6KA2 | 0.72682175 |
79 | ABL2 | 0.71846821 |
80 | STK3 | 0.70895203 |
81 | MAPK12 | 0.68853036 |
82 | EPHA2 | 0.67371145 |
83 | FRK | 0.65453059 |
84 | STK38L | 0.64730356 |
85 | CSF1R | 0.64069136 |
86 | CDK4 | 0.63817599 |
87 | PAK4 | 0.63472870 |
88 | MAP3K14 | 0.63430624 |
89 | DYRK1B | 0.63221125 |
90 | KIT | 0.61807842 |
91 | IKBKE | 0.59312977 |
92 | TGFBR1 | 0.59147846 |
93 | ERBB2 | 0.59019654 |
94 | IKBKB | 0.58482763 |
95 | GSK3A | 0.58218482 |
96 | LYN | 0.58021573 |
97 | PDK1 | 0.57951506 |
98 | IRAK3 | 0.57574883 |
99 | CAMK1G | 0.57444847 |
100 | SIK3 | 0.56767255 |
101 | PTK2B | 0.54882521 |
102 | ITK | 0.54521930 |
103 | MAPK4 | 0.54419897 |
104 | RPS6KA4 | 0.54221354 |
105 | TNK2 | 0.53876992 |
106 | RET | 0.53291848 |
107 | SYK | 0.53004342 |
108 | PAK2 | 0.52839162 |
109 | RAF1 | 0.51335594 |
110 | DMPK | 0.49930843 |
111 | BTK | 0.49794589 |
112 | ROCK2 | 0.49695367 |
113 | LATS2 | 0.48994499 |
114 | DDR2 | 0.48518426 |
115 | HIPK2 | 0.48171677 |
116 | FGFR1 | 0.47765234 |
117 | PRKG2 | 0.47757040 |
118 | SGK3 | 0.47052970 |
119 | MAP3K2 | 0.46856849 |
120 | EPHB2 | 0.46347301 |
121 | RPS6KC1 | 0.46156046 |
122 | RPS6KL1 | 0.46156046 |
123 | CHUK | 0.46114010 |
124 | YES1 | 0.45416545 |
125 | CDK12 | 0.44483722 |
126 | PRKAA1 | 0.43642977 |
127 | PDGFRB | 0.43234736 |
128 | MAP2K2 | 0.42221072 |
129 | EGFR | 0.40437915 |
130 | FER | 0.39121006 |
131 | MAP2K1 | 0.38723991 |
132 | PDPK1 | 0.38081444 |
133 | MAPKAPK3 | 0.36290915 |
134 | IGF1R | 0.35975200 |
135 | PRKD1 | 0.35893011 |
136 | HCK | 0.33726626 |
137 | PRKACG | 0.33248894 |
138 | PRKCZ | 0.31951114 |
139 | MAPK7 | 0.30592067 |
140 | MAP2K6 | 0.28946199 |
141 | MAP3K5 | 0.28861758 |
142 | MAP3K8 | 0.28816317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20550795 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47180176 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43111317 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25672907 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99784058 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80995175 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62770873 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60139893 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56610181 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55092643 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39270212 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37600716 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20415087 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14808191 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05552740 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98054638 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96542973 |
18 | Peroxisome_Homo sapiens_hsa04146 | 1.95885723 |
19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94887916 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93920228 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91565843 |
22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90917430 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90436966 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.86844102 |
25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78935321 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77973746 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77726448 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75926829 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73262826 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72371766 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70454163 |
32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67418872 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60600155 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55893802 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55405976 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52877156 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52790589 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52063000 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50597672 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.46095141 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45308474 |
42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41306973 |
43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37302252 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 1.36855211 |
45 | Phagosome_Homo sapiens_hsa04145 | 1.33853471 |
46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33250393 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32786317 |
48 | Platelet activation_Homo sapiens_hsa04611 | 1.31825541 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29593506 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28695664 |
51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27750011 |
52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24821728 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23850755 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23029944 |
55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22102237 |
56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20476044 |
57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20360417 |
58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18646077 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18414244 |
60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18302155 |
61 | ABC transporters_Homo sapiens_hsa02010 | 1.16193097 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14293045 |
63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13227841 |
64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11437007 |
65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11285300 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10773598 |
67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10544688 |
68 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08442269 |
69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07365300 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 1.06466076 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06221116 |
72 | Shigellosis_Homo sapiens_hsa05131 | 1.05821488 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05607912 |
74 | Allograft rejection_Homo sapiens_hsa05330 | 1.02127821 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99689277 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98574216 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98286798 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97205658 |
79 | Endocytosis_Homo sapiens_hsa04144 | 0.96805634 |
80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96529087 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96449468 |
82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96432361 |
83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94471346 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92899412 |
85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92802316 |
86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92442397 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91241362 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90877903 |
89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90294689 |
90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89991257 |
91 | Influenza A_Homo sapiens_hsa05164 | 0.88295399 |
92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86947569 |
93 | Salmonella infection_Homo sapiens_hsa05132 | 0.86440896 |
94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86163217 |
95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85704262 |
96 | Apoptosis_Homo sapiens_hsa04210 | 0.85051070 |
97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83094318 |
98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82549232 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80949796 |
100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80582753 |
101 | Hepatitis B_Homo sapiens_hsa05161 | 0.79421757 |
102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79246631 |
103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78324466 |
104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75303836 |
105 | Measles_Homo sapiens_hsa05162 | 0.75084355 |
106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74204437 |
107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72738591 |
108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72324852 |
109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72319633 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72273046 |
111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72150665 |
112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71988905 |
113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71578231 |
114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70322774 |
115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66911373 |
116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66379522 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65315912 |
118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64258019 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63412386 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63273724 |
121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63253910 |
122 | Glioma_Homo sapiens_hsa05214 | 0.61150358 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.60892572 |
124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60424661 |
125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60111474 |
126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58993262 |
127 | Adherens junction_Homo sapiens_hsa04520 | 0.58471072 |
128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57980114 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.57892217 |
130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57781432 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57547716 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57207623 |
133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56796816 |
134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56500546 |
135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53078355 |
136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53001127 |
137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51710227 |
138 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51061495 |
139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50590087 |
140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50372203 |
141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50125034 |
142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49809327 |
143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49049845 |
144 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48387769 |
145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46056066 |
146 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36826231 |
147 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32910116 |
148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31075281 |
149 | Prion diseases_Homo sapiens_hsa05020 | 0.29108467 |
150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26109575 |
151 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22938284 |
152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22249637 |
153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19035028 |
154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14156358 |
155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10384441 |
156 | Amoebiasis_Homo sapiens_hsa05146 | 0.09093052 |
157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07944280 |
158 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07851492 |
159 | Bladder cancer_Homo sapiens_hsa05219 | 0.06397315 |
160 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05976081 |
161 | Hepatitis C_Homo sapiens_hsa05160 | 0.01019454 |
162 | Lysosome_Homo sapiens_hsa04142 | 0.00274339 |
163 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0829312 |
164 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0787959 |
165 | Focal adhesion_Homo sapiens_hsa04510 | -0.0755828 |
166 | Legionellosis_Homo sapiens_hsa05134 | -0.0709566 |
167 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0699829 |
168 | Pertussis_Homo sapiens_hsa05133 | -0.0578193 |
169 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0517910 |
170 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0502883 |
171 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0429647 |
172 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0360388 |
173 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0347924 |
174 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0345588 |
175 | Malaria_Homo sapiens_hsa05144 | -0.0267081 |
176 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0204997 |
177 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0135686 |